We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Spironolactone for Reducing Proteinuria in Diabetic Nephropathy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00498537
Recruitment Status : Completed
First Posted : July 10, 2007
Last Update Posted : October 17, 2008
Information provided by:
VA Office of Research and Development